Decoding human biology through light and AI.

Optomics® - a photonics-powered AI engine for clinical
diagnostics, trial stratification, and drug development.

Explore the platform
Partner with us

iLOF is built on a simple conviction: the time for personalised medicine is now.

Close-up of transparent soap bubbles joining together with smooth reflective surfaces.

Science has long shown that generalized treatments overlook individual biological differences - limiting therapeutic effectiveness and patient outcomes.

We're changing that.

By bringing individualized biology into clinical development and decision-making, iLOF is helping move medicine from generalized care to truly personalized outcomes.

Young girl with curly hair and freckles wearing a maroon sweater, resting her hand on a wooden surface.
Close-up of dark brown human skin showing natural texture and pores.
Close-up macro image of a blue and brown human eye iris with intricate texture details.
Hand gently touching water surface creating soft ripples in warm light.

How Optomics differs fromtraditional -omics.

Imagine reading the following:

This is why Optomics® doesn't just analyze biology — it reconstructs the complete story each patient's biology is telling.

A woman in a house.A forest with tall trees.A coat-hanger with a red cloak.A wolf. A little girl.

You recognise the elements, but you still don't know what's really happening, or what story is being told.

That's how traditional -omics data often work.

Genomics, transcriptomics, proteomics, and metabolomics each provide powerful insights — but in isolation, they offer only fragments of the biological story.

Optomics® takes a different approach: the whole is more than the sum of its parts.

Instead of analyzing biology one layer at a time, our engine captures integrated, system-level signals to build a complete digital biological fingerprint. This allows us to move beyond disconnected data points — and toward a coherent biological narrative that reveals clinically meaningful patterns no single -omics layer can.

WHERE OPTOMICS® CREATES VALUE

From discovery to the clinic.

(01)
Clinical pathways
Stratify patients, predict responses, and guide treatment decisions with high-resolution biological signals.
applications
(02)
Clinical trials
Objective stratification. Reduced screening failures. Faster recruitment, from months to days.
applications
(03)
Drug development
Nanoparticle analytics. Real-time characterization. Shorter R&D cycles from lab to formulation.
applications

Built for clinical rigor.
Validated at scale.

7
completed
case studies
9
countries
50+
clinical sites
6
patents granted
6 years
biomarker library
Dropper releasing a clear liquid droplet above an open petri dish on a light background.
Investors and Partners
Partner institutions
Monolith™
terra—tory™
FRANCO®
Superior Space®
• Strobe™

CE marked*

Selected device components

ISO 13485

Medical device quality management

3 trademarks

Registered IP portfolio

*Note: This device is CE-marked and classified exclusively as RUO (Research Use Only), intended for use in clinical or pre-clinical discovery and development.

The future of personalized medicine is being built now. Be in it.

INVESTORS & PARTNERS

Follow our milestones, clinical validation updates, and platform releases.

subscribe for updates
CROS & SPONSORS

Explore how Optomics® fits your next study. Let's talk.

Contact us